Articles from Benzinga
Options Corner: Why Paying For Extra Coverage Makes Sense For MARA Holdingsbenzinga.com
While MARA Holdings may rise alongside the rest of the blockchain ecosystem, certain behavioral risks warrant a special options strategy.
Via Benzinga · January 23, 2025
TikTok Ban Effect: Smartphones With App Installed Hit Ebaybenzinga.com
Can't download TikTok while app stores support the ban? A smartphone with TikTok awaits you on eBay for thousands of dollars.
Via Benzinga · January 23, 2025
11 Analysts Assess Paycom Software: What You Need To Knowbenzinga.com
Via Benzinga · January 23, 2025
Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · January 23, 2025
Deep Dive Into Travelers Companies Stock: Analyst Perspectives (9 Ratings)benzinga.com
Via Benzinga · January 23, 2025
BankUnited Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)benzinga.com
Via Benzinga · January 23, 2025
A Glimpse Into The Expert Outlook On Comerica Through 16 Analystsbenzinga.com
Via Benzinga · January 23, 2025
Decentralized Perpetuals Exchanges (DEXs): A Comprehensive Guide To The Future Of Crypto Tradingbenzinga.com
Via Benzinga · January 23, 2025
Lightbridge Stock Is Surging Today: What's Going On?benzinga.com
Lightbridge Corporation (NASDAQLTBR) shares are trading higher Thursday after the company announced a collaboration agreement with Oklo Inc. NYSE:OKLONYSEOKLO)
Via Benzinga · January 23, 2025
The Future of Finance: 3 Fintech Stocks Set to Take Wall Street by Storm in 2025benzinga.com
Via Benzinga · January 23, 2025
Here's How Much You Would Have Made Owning AECOM Stock In The Last 10 Yearsbenzinga.com
Via Benzinga · January 23, 2025
Hyundai Clocks Mixed Q4: Revenue Climbs 12% While Operating Profit Slips On Warranty Costsbenzinga.com
Hyundai Motor reports 1.1M units sold globally in Q4, revenue up 11.9%, operating profit down 17.2%. Plans 3-4% revenue growth for FY25.
Via Benzinga · January 23, 2025
Decoding Apollo Global Management's Options Activity: What's the Big Picture?benzinga.com
Via Benzinga · January 23, 2025
Is Your 401(k) Balance Above Average? Find Out If You're Beating Most Saversbenzinga.com
Via Benzinga · January 23, 2025
American Express Stock Climbs Ahead Of Earnings, Signals Show Potential Coolingbenzinga.com
American Express (AXP) reports Q4 earnings with expected EPS of $3.04 and revenues of $17.16B. Stock is reaching new 52-week high of $326.27 before report. Charts show bullish trend.
Via Benzinga · January 23, 2025
General Motors Shares Are Rising Today: What's Going On?benzinga.com
General Motors Co. (NYSEGM) shares are trading higher Thursday on reports the company and Hyundai are forging an EV partnership for North America.
Via Benzinga · January 23, 2025
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Via Benzinga · January 23, 2025
NextEra Energy: Charging Into Q4 Earnings — Will Clean Energy's Powerhouse Keep Its Momentum?benzinga.com
NextEra Energy to report Q4 earnings Friday before market opens. Expected EPS: 52 cents & revenue: $7.53 billion.
Via Benzinga · January 23, 2025
Halliburton Analysts Trim Forecasts After Softer 2025 Guidancebenzinga.com
Several analysts lowered price target for Halliburton (HAL) mixed Q4 results and weak guidance. Stifel, Goldman Sachs, Piper Sandler revised estimates.
Via Benzinga · January 23, 2025
Here's How Much You Would Have Made Owning Teledyne Technologies Stock In The Last 20 Yearsbenzinga.com
Via Benzinga · January 23, 2025
Verizon Q4 Earnings Preview: Will Company Show 5G Growth, Reverse Streak Of Revenue Misses?benzinga.com
Verizon will likely highlight its growth in 5G and recent partnerships when the company reports Q4 financial results on Friday.
Via Benzinga · January 23, 2025
Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analystbenzinga.com
Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Via Benzinga · January 23, 2025
FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drugbenzinga.com
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention.
Via Benzinga · January 23, 2025
Why Is Abbott Stock Trading Higher On Thursday?benzinga.com
Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.
Via Benzinga · January 23, 2025
Forecasting The Future: 12 Analyst Projections For CACI Internationalbenzinga.com
Via Benzinga · January 23, 2025
Forecasting The Future: 9 Analyst Projections For ZoomInfo Technologiesbenzinga.com
Via Benzinga · January 23, 2025
Breaking Down Caesars Entertainment: 11 Analysts Share Their Viewsbenzinga.com
Via Benzinga · January 23, 2025
Demystifying Brinker International: Insights From 15 Analyst Reviewsbenzinga.com
Via Benzinga · January 23, 2025
Here's How Much $1000 Invested In Walmart 5 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · January 23, 2025
Ivanka Trump Denounces Fake Crypto Coin Using Her Namebenzinga.com
Ivanka Trump on Thursday publicly disavowed any connection to a cryptocurrency meme coin being promoted under her name, issuing a strong warning to consumers against falling prey to fraud.
Via Benzinga · January 23, 2025
Procter & Gamble's Q2 Surge: Optimism Grows Amid Stable US Sales, Improving Trends In Chinabenzinga.com
Procter & Gamble posts strong Q2 results with 3% organic sales growth, prompting analysts to raise price targets amid improving trends in key markets.
Via Benzinga · January 23, 2025
Looking Into Jefferies Financial Gr's Recent Short Interestbenzinga.com
Via Benzinga · January 23, 2025
Dow Jones Nears Records, Tech Pulls Back, Treasury Yields Rise Again: What's Driving Markets Thursday?benzinga.com
Wall Street traded slightly higher during midday Thursday as investors assessed the ongoing earnings season while closely monitoring policy signals from President Donald Trump.
Via Benzinga · January 23, 2025
Construction Partners Stock Cracks Under Pressure As Short Seller Warns Of Potential 50% Downsidebenzinga.com
Short-selling investment management firm Spruce Point released a new research report on Construction Partners titled, "An As-Faulty Investment," claiming the company's business is under pressure and faces 35% to 50% downside.
Via Benzinga · January 23, 2025
GE Aerospace Beats Expectations Across The Board: Analyst Sees Upside In 2025 Guidancebenzinga.com
Goldman Sachs analyst Noah Poponak positive on GE Aerospace's Q4 earnings, expects growth in FY25. Stock rated Buy with price target of $204.
Via Benzinga · January 23, 2025
Wall Street Eyes Intuitive Surgical Q4 Earnings As Stock Hits New Heightsbenzinga.com
Intuitive Surgical's Q4 earnings report on Thursday expected to be $1.79 EPS and $2.25B revenue.
Via Benzinga · January 23, 2025
US Health Agency CMS To Appeal Medicare Star Ratings Recalculation Rulingbenzinga.com
CMS appeals Medicare Star Rating ruling after a judge sided with UnitedHealth over unfair evaluations, impacting the 2025 plan assessments.
Via Benzinga · January 23, 2025
Morgan Stanley CEO Says Meme Coins Are A Sign 'Liquidity' In Cryptobenzinga.com
Morgan Stanley (NASDAQMSPQ) CEO Ted Pick sees the recent launches of presidential meme coins as a result of substantial liquidity in the cryptocurrency ecosystem.
Via Benzinga · January 23, 2025
C-Suite Buy of the Week: Executive Moves from Biotech to Bankingbenzinga.com
Via Benzinga · January 23, 2025
Tesla Lost $15 Billion In Brand Value In 2024, Report Says: Did Elon Musk's Political Push Hurt EV Giant?benzinga.com
Tesla's brand value fell in 2024 and the company drops down the top 100 list from Brand Finance, thanks in part to Elon Musk's political push.
Via Benzinga · January 23, 2025
The Analyst Verdict: Gulfport Energy In The Eyes Of 6 Expertsbenzinga.com
Via Benzinga · January 23, 2025
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stockbenzinga.com
Via Benzinga · January 23, 2025
What's Going On With Nikola Stock On Thursday?benzinga.com
Nikola's stock falls after bankruptcy rumors surface, and a significant decline in revenue amid recent ongoing fraud allegations.
Via Benzinga · January 23, 2025
Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Businessbenzinga.com
Dr. Reddy's Q3 FY2025 revenue reached $977 million, up 16%, with $165M net income. Growth fueled by NRT portfolio and global generics expansion.
Via Benzinga · January 23, 2025
Diamondback Energy Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)benzinga.com
Via Benzinga · January 23, 2025
Expert Outlook: Wintrust Finl Through The Eyes Of 6 Analystsbenzinga.com
Via Benzinga · January 23, 2025
GE Vernova's Q4 Was Not Perfect, But Analyst Bumps Up Price Forecast On Continued Orders Strengthbenzinga.com
BofA Securities raised GE Vernova's target price to $485, while reiterating a Buy rating. Q4 revenue grew 5%, but earnings missed consensus.
Via Benzinga · January 23, 2025
Electronic Arts' Growth Questioned: Analyst Downgrades Stock Amid Struggles In Gaming Engagementbenzinga.com
BofA Securities downgrades Electronic Arts from Buy to Neutral, citing weak player engagement and potential structural issues in the gaming market.
Via Benzinga · January 23, 2025